Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | CMA1 | P23946 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15822934 | 0.92 | FFAR1 (0.44) | MAOBTSHRTRPA1ALDH1A1FFAR1 | |
| SCHEMBL9147038 | 0.91 | TRPA1 (0.40) | MAOBTSHRTRPA1ALDH1A1SMN1; SMN2 | |
| Tetrahydrofuran SCHEMBL28855326 | 0.90 | HSD11B1 (0.40) | MAOBTSHRTRPA1ALDH1A1CCR5 | |
| SCHEMBL9148468 | 0.89 | HSD11B1 (0.40) | MAOBTSHRTRPA1ALDH1A1 | |
| SCHEMBL17135362 | 0.89 | TSHR (0.39) | MAOBTSHRTRPA1ALDH1A1CCR5 | |
| SCHEMBL9144305 | 0.85 | L3MBTL1 (0.40) | TRPA1ALDH1A1SMN1; SMN2CCR5 | |
| SCHEMBL31440790 | 0.84 | HTR6 (0.42) | TSHRALDH1A1 | |
| SCHEMBL12162441 | 0.83 | DDB1 (0.49) | MAOBALDH1A1LMNA | |
| SCHEMBL1785146 | 0.83 | MAOB (0.42) | MAOBTSHRALDH1A1SMN1; SMN2CMA1 | |
| SCHEMBL15641193 | 0.83 | MAOB (0.38) | MAOBTSHRTRPA1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118930414-B | Synthetic process method of 5- [ (4-chlorophenyl) methyl ] -2, 2-dimethyl cyclopentanone | 淮北龙溪生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119390657-A | Novel process for synthesizing high-purity metconazole | 江苏剑牌农化科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119118933-A | Green preparation method of metconazole | 江苏剑牌农化科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118930414-A | Synthetic process method of 5- [ (4-chlorophenyl) methyl ] -2, 2-dimethyl cyclopentanone | 淮北龙溪生物科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118146096-A | 2, 2-Dimethyl-5- (4-chlorobenzyl) cyclopentanone derivative and preparation method thereof | 浙江大学 | 2024-06-07 | — | — | CN | claimed |
| CN-118084640-A | Preparation method of metconazole key intermediate 5- (4-chlorophenyl) methyl-2, 2-dimethylcyclopentanone | 临海市建新化工有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-114773279-B | Novel synthesis method of metconazole | 浙江工业大学 | 2023-12-05 | — | — | CN | claimed |
| CN-114773279-A | Novel synthesis method of metconazole | 浙江工业大学 | 2022-07-22 | — | — | CN | claimed |
| CN-113429273-A | Synthesis method of metconazole intermediate | 江苏省农用激素工程技术研究中心有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-106045830-B | Preparation method of 2, 2-dimethyl-5- (4-chlorobenzyl) cyclopentanone | 上海试四赫维化工有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-104591989-A | Method for preparing 5-[(4-chlorophenyl)methyl]-2,2-dimethyl-cyclopentanone | SHANGHAI HUAYI GROUP CO | 2015-05-06 | — | — | CN | claimed |
| US-7166750-B1 | Process for the preparation of 5-[(4-chlorophenyl)methyl]-2,2-dimethylcyclopentanone | KUREHA CORPORATION (JP) | 2007-01-23 | — | — | US | claimed |
| EP-1308432-B1 | PROCESS FOR THE PREPARATION OF 5- (4-CHLOROPHENYL)-METHYL|-2,2-DIMETHYLCYCLOPENTANONE | KUREHA CORP (JP) | 2006-10-18 | — | — | EP | claimed |
| EP-1289938-B1 | A PROCESS FOR THE PREPARATION OF 2,2-DIMETHYL-5-(4-CLOROBENZYL) CYCLOPENTANONE AND AN INTERMEDIATE USEFUL THEREFOR | BASF AG (DE) | 2004-05-12 | — | — | EP | claimed |
| CN-1454200-A | Process for the preparation of 5-[4-chlorophenyl)-methyl]-2, 2-dimethylcyclopentanone | KUREHA CHEMICAL IND CO LTD (JP) | 2003-11-05 | — | — | CN | claimed |
| EP-1308432-A1 | PROCESS FOR THE PREPARATION OF 5- (4-CHLOROPHENYL)-METHYL]-2,2-DIMETHYLCYCLOPENTANONE | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-05-07 | — | — | EP | claimed |
| EP-1289938-A2 | A PROCESS FOR THE PREPARATION OF 2,2-DIMETHYL-5-(4-CLOROBENZYL) CYCLOPENTANONE AND AN INTERMEDIATE USEFUL THEREFOR | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-12 | — | — | EP | claimed |
| US-6344580-B1 | CHEMICAL INTERMEDIATE FOR FUNGICIDE | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-05 | — | — | US | claimed |
| US-20020013489-A1 | Process for the preparation of 2,2-dimethyl-5-(4-chlorobenzyl) cyclopentanone and an intermediate useful therefore | BASF AKTIENEGESELLSCHAFT (DE) | 2002-01-31 | — | — | US | claimed |
| WO-2002000608-A2 | A PROCESS FOR THE PREPARATION OF 2,2-DIMETHYL-5-(4-CHLOROBENZYL) CYCLOPENTANONE AND AN INTERMEDIATE USEFUL THEREFOR | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013489-A1 | Process for the preparation of 2,2-dimethyl-5-(4-chlorobenzyl) cyclopentanone and an intermediate useful therefore | CYP51A1, CYP4B1, CYP1B1 | MAOB 931/4885TSHR 4792/4885TRPA1 4698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.